Technology
Health
Medical

Avadel Pharmaceuticals

$1.34
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (1.52%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell AVDL and other stocks, options, ETFs, and crypto commission-free!

About

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. Read More The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

Employees
144
Headquarters
Dublin, Dublin
Founded
2015
Market Cap
49.31M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
219.38K
High Today
$1.39
Low Today
$1.31
Open Price
$1.31
Volume
114.87K
52 Week High
$7.97
52 Week Low
$1.03

Collections

Technology
Health
Medical
Pharmaceutical
Europe (Non-UK)
Europe

News

Seeking AlphaMay 8

Avadel Pharmaceuticals (AVDL) Interim CEO Greg Divis on Q1 2019 Results - Earnings Call Transcript

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2019 Earnings Conference Call May 8, 2019 8:30 AM ET Company Participants Greg Divis - Interim CEO Mike Kanan - CFO Jordon Dubow - CMO Geoff Glass - Chairman Conference Call Participants Operator Good morning, ladies and gentlemen, thank you for standing by. And welcome to the Avadel Pharmaceuticals’ First Quarter 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer s...

46
Yahoo FinanceMay 8

Avadel Pharmaceuticals Reports First Quarter 2019 Financial Results

31
Yahoo FinanceMay 8

Introducing Avadel Pharmaceuticals (NASDAQ:AVDL), The Stock That Tanked 82%

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Even the best investor on earth makes unsuccessful investments. But it would be foolish to simply accept every extremely large loss as an inevitable part of the game. So spare a thought for the long term shareholders of Avadel Pharmaceuticals plc (NASDAQ:AVDL); the share price is down a whopping 82% in the last twelve months. A loss like this is a stark reminder that portfolio diversi...

27

Earnings

-$2.34
-$1.65
-$0.97
-$0.28
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.44 per share
Actual
-$0.28 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.